Distinctive genomic features of human T-lymphotropic virus type 1-related adult T-cell leukemia-lymphoma in Western populations

• Published in: Haematologica (Roma) Vol. 999; no. 1
• Main Authors: Myers, Caroline S, Williams, Eli, Cornejo, Carlos Barrionuevo, Pongas, Georgios, Toomey, Ngoc L, Sanches, Jose A, Battistella, Maxime, Mo, Samuel, Pulitzer, Melissa, Moskaluk, Cristopher A, Bhagat, Govind, Ofori, Kenneth, Davick, Jonathan J, Servitje, Octavio, Miyashiro, Denis, Climent, Fina, Ringbloom, Kimberley, Duenas, Daniela, Law, Calvin, Zambrano, Sandro Casavilca, Malpica, Luis, Beltran, Brady E, Castro, Denisse, Barreto, Luciana, Brites, Carlos, Chapman, Jennifer R, Choi, Jaehyuk, Gru, Alejandro A, Ramos, Juan C
• Format: Journal Article
• Language: English
• Published: Italy Ferrata Storti Foundation 08-08-2024
• ISSN: 0390-6078; 1592-8721; 1592-8721
• DOI: 10.3324/haematol.2024.285233

Adult T-cell leukemia-lymphoma (ATLL) is an aggressive Human T-cell Leukemia Virus Type 1 (HTLV-1)-driven malignancy. Although Western hemisphere (Afro-Caribbean and South American) patients face worse prognoses, our understanding of ATLL molecular drivers derives mostly from Japanese studies. We performed multi-omic analyses to elucidate the genomic landscape of ATLL in Western cohorts. Recurrent deletion and/or damaging mutations involving FOXO3, ANKRD11, DGKZ, and PTPN6 implicate these genes as potential tumor suppressors. RNA-seq, published functional data and in vitro assays support the roles of ANKRD11 and FOXO3 as regulators of T-cell proliferation and apoptosis in ATLL, respectively. Survival data suggest ANKRD11 mutation may confer a worse prognosis. Japanese and Western cohorts, in addition to acute and lymphomatous subtypes, demonstrated distinct molecular patterns. GATA3 deletion was associated with unfavorable chronic cases. IRF4 and CARD11 mutations frequently emerged in relapses after interferon therapy. Our findings reveal novel putative ATLL driver genes and clinically relevant differences between Japanese and Western ATLL patients.